Since hormone replacement therapy given for long periods is now recognised to produce serious side effects, patients with troublesome vasomotor symptoms are increasingly using non-hormonal treatment including acupuncture. Several randomised controlled trials have shown that acupuncture reduces menopausal symptoms in patients experiencing the normal climacteric. It may have this effect by raising serotonin levels which alter the temperature set point in the hypothalamus. Vasomotor symptoms can be extreme in breast cancer patients and patients with prostate cancer who are undergoing anticancer therapy. The safety of some herbal medicines and phytoestrogens has been questioned, as they could potentially interfere adversely with the bioavailability of tumouricidal drugs. A previous study reports short term benefit from acupuncture, and the aim of this report is to describe our approach to long term treatment.
Acupuncture Approach
After piloting several approaches, six weekly treatments were given initially at LI4, TE5, LR3 and SP6 and two upper sternal points, but avoiding any limb with existing lymphoedema or prone to developing it. If there were no contraindications, patients were given clear instructions on how to perform self acupuncture using either semi-permanent needles or conventional needling at SP6, weekly for up to six years, for long term maintenance.
Audit Methods and Results
A retrospective audit of electronic records was carried out by a doctor not involved in treatment. A total of 194 patients were treated, predominantly with breast and prostate cancer. One hundred and eighty two patients were female. The number of pre-treatment hot flushes per day was estimated by the patient: in the 159 cases providing adequate records, the mean was 16 flushes per day. Following treatment, 114 (79%) gained a 50% or greater reduction in hot flushes and 30 (21%) a less than 50% reduction. Treatment was abandoned in those who responded poorly or not at all. The duration of treatment varied from one month to over six years with a mean duration of nine months. Seventeen patients (9%) experienced minor side effects over the six year period, mostly minor rashes; one patient described leg swelling but this was likely to be due to a concurrent fracture.
Conclusion
Acupuncture including self acupuncture is associated with long term relief of vasomotor symptoms in cancer patients. Treatment is safe and costs appear to be low. An algorithm is presented to guide clinical use. We recommend the use of self acupuncture with needles at SP6 in preference to semi-permanent needles in the first instance, but poor responders use indwelling studs if they fail to respond adequately to self acupuncture with regular needles. Point location may be of less importance than the overall ‘dose’, and an appropriate minimum dose may be required to initiate the effect.
Get full access to this article
View all access options for this article.
References
1.
ShanafeltT.D., BartonD.L., AdjeiA.A., LoprinziC.L.Pathophysiology and treatment of hot flashes. Mayo Clin Proc2002; 77(11): 1207–18.
2.
RossouwJ.E., AndersonG.L., PrenticeR.L., LaCroixA.Z., KooperbergC., StefanickM.L.Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA2002; 288(3): 321–33.
3.
GabrielS.R., CarmonaL., RoqueM., SanchezG.L., BonfillX.Hormone replacement therapy for preventing cardiovascular disease in postmenopausal women. Cochrane Database Syst Rev2005; (2): CD002229.
4.
EwertzM., MellemkjaerL., PoulsenA.H., FriisS., SorensenH.T., PedersenL.Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study. Br J Cancer2005; 92(7): 1293–7.
5.
BeralV., BullD., ReevesG.Million Women Study Collaborators. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet2005; 365(9470): 1543–51.
6.
TaylorM.Alternative medicine and the perimenopause an evidence-based review. Obstet Gynecol Clin North Am2002; 29(3): 555–73.
7.
SeidlM.M., StewartD.E.Alternative treatments for menopausal symptoms. Systematic review of scientific and lay literature. Can Fam Physician1998; 44: 1299–308.
8.
AlbertazziP., PurdieD.The nature and utility of the phytoestrogens: a review of the evidence. Maturitas2002; 42(3): 173–85.
9.
WymengaA.N., SleijferD.T.Management of hot flushes in breast cancer patients. Acta Oncol2002; 41(3): 269–75.
10.
PhilpH.A.Hot flashes—a review of the literature on alternative and complementary treatment approaches. Altern Med Rev2003; 8(3): 284–302.
11.
LuceroM.A., McCloskeyW.W.Alternatives to estrogen for the treatment of hot flashes. Ann Pharmacother1997; 31(7-8): 915–7.
12.
McPhailG., SmithL.N.Acute menopause symptoms during adjuvant systemic treatment for breast cancer: a case-control study. Cancer Nurs2000; 23(6): 430–43.
13.
HarrisP.F., RemingtonP.L., Trentham-DietzA., AllenC.I., NewcombP.A.Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manage2002; 23(6): 501–9.
14.
CarpenterJ.S., AndrykowskiM.A., CordovaM., CunninghamL., StudtsJ., McGrathP.Hot flashes in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life. Cancer1998; 82(9): 1682–91.
15.
HammarM., FriskJ., GrimasO., HookM., SpetzA.C., WyonY.Acupuncture treatment of vasomotor symptoms in men with prostatic carcinoma: a pilot study. J Urol1999; 161(3): 853–6.
16.
ParmarH., EdwardsL., PhillipsR.H., AllenL., LightmanS.L.Orchiectomy versus long-acting D-Trp-6-LHRH in advanced prostatic cancer. Br J Urol1987; 59(3): 248–54.
17.
SmithJ.A.Jr.. Androgen suppression by a gonadotropin releasing hormone analogue in patients with metastatic carcinoma of the prostate. J Urol1984; 131(6): 1110–2.
18.
Early Breast Cancer Trialists’ Collaborative Group.Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet1998; 351(9114): 1451–67.
19.
LoveR.R., CameronL., ConnellB.L., LeventhalH.Symptoms associated with tamoxifen treatment in postmenopausal women. Arch Intern Med1991; 151(9): 1842–7.
20.
WatsonM., HavilandJ.S., GreerS., DavidsonJ., BlissJ.M.Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet1999; 354(9187): 1331–6.
21.
KarlingP., HammarM., VarenhorstE.Prevalence and duration of hot flushes after surgical or medical castration in men with prostatic carcinoma. J Urol1994; 152(4): 1170–3.
22.
SchiffI., TulchinskyD., CramerD., RyanK.J.Oral medroxyprogesterone in the treatment of postmenopausal symptoms. JAMA1980; 244(13): 1443–5.
23.
LoprinziC.L., MichalakJ.C., QuellaS.K., O'FallonJ.R., HatfieldA.K., NelimarkR.A.Megestrol acetate for the prevention of hot flashes. N Engl J Med1994; 331(6): 347–52.
24.
WrenB.G., BrownL.B.Adouble-blind trial with clonidine and a placebo to treat hot flushes. Med J Aust1986; 144(7): 369–70.
25.
StearnsV., IsaacsC., RowlandJ., CrawfordJ., EllisM.J., KramerR.A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Ann Oncol2000; 11(1): 17–22.
26.
StearnsV., BeebeK.L., IyengarM., DubeE.Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA2003; 289(21): 2827–34.
27.
LoprinziC.L., KuglerJ.W., SloanJ.A., MailliardJ.A., LaVasseurB.I., BartonD.L.Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet2000; 356(9247): 2059–63.
28.
GuttusoT.Jr., KurlanR., McDermottM.P., KieburtzK.Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol2003; 101(2): 337–45.
29.
HofsethL.J., RaafatA.M., OsuchJ.R., PathakD.R., SlomskiC.A., HaslamS.Z.Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J Clin Endocrinol Metab1999; 84(12): 4559–65.
30.
HuntleyA.L., ErnstE.Asystematic review of herbal medicinal products for the treatment of menopausal symptoms. Menopause2003; 10(5): 465–76.
31.
HuntleyA.L., ErnstE.Soy for the treatment of perimenopausal symptoms: a systematic review. Maturitas2004; 47(1): 1–9.
32.
DavisV. L., JayoM. J., HardyM. L., HoA., LeeH., ShaikhF., FosterW. G., and HughesC. L.Jr.Effects of black cohosh on mammary tumor development and progression in MMTV-neu transgenic mice. Proceedings of the AACR44(2nd). 2003.
WernekeU., EarlJ., SeydelC., HornO., CrichtonP., FannonD.Potential health risks of complementary alternative medicines in cancer patients. Br J Cancer2004; 90(2): 408–13.
35.
MarkowitzJ.S., DonovanJ.L., DeVaneC.L., TaylorR.M., RuanY., WangJ.S.Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA2003; 290(11): 1500–4.
36.
FryeR.F., FitzgeraldS.M., LagattutaT.F., HruskaM.W., EgorinM.J.Effect of St John's wort on imatinib mesylate pharmacokinetics. Clin Pharmacol Ther2004; 76(4): 323–9.
37.
MathijssenR.H., VerweijJ., deB.P., LoosW.J., SparreboomA.Effects of St. John's wort on irinotecan metabolism. J Natl Cancer Inst.2002; 94(16): 1247–9
38.
De GiacomoE.Céphalée et syndrome climatérique. La Revue Française de Médicine Traditionnelle Chinoise1989; 133: 60–1.
39.
WyonY., LindgrenR., HammarM., LundebergT.[Acupuncture against climacteric disorders? Lower number of symptoms after menopause]. Lakartidningen1994; 91(23): 2318–22.
40.
WyonY., LindgrenR., LundebergT., HammarM.Effects of Acupuncture on Climacteric Vasomotor Symptoms, Quality of Life, and Urinary Excretion of Neuropeptides Among Post Menopausal Women. Menopause1995; 2(1): 3–12.
SandbergM, WijmaK., WyonY, NedstrandE., HammarM.Effects of electro-acupuncture on psychological distress in postmenopausal women. Complement Ther Med2002; 10(3): 161–9.
43.
TowlertonG, FilshieJ., O'BrienM., DuncanA.Acupuncture in the control of vasomotor symptoms caused by tamoxifen [letter]. Palliat Med1999; 13(5): 445.
44.
TukmachiE.Treatment of hot flushes in breast cancer patients with acupuncture. Acupunct Med2000; 18(1): 22–7.
45.
CumminsS.M., BruntA.M.Does acupuncture influence the vasomotor symptoms experienced by breast cancer patients taking tamoxifen?Acupunct Med2000; 18(1): 28.
46.
de ValoisB., JacksonL.Using traditional acupuncture for hot flushes and night sweats in women taking Tamoxifen - a pilot study. British Acupuncture Council News2003; 8(1): 24.
47.
PerezA.T., SearA., FrankelC., FrancoS.X., Tan-ChiuE., GokceF.Acupuncture for the management of hot flashes in women with early stage breast cancer treated with tamoxifen or an aromatase inhibitor: A pilot study of efficacy, safety and feasibility. J Clin Oncol2005; 23(16S): 53s.
48.
de ValoisB., YoungT., RobinsonN., McCourtC., MaherE.J.Evaluating the effects of the NADA protocol on physical and emotional well-being in women undergoing adjuvant treatment for early breast cancer. Focus on Alternative and Complementary Therapies2005; 10(Supplement 1): 14–5.
49.
HayesM., KatovicN.M., DonovanD., EmmonsS., BenavidesM., MontaltoM.Acupuncture for hot flashes in prostate cancer patients. J Clin Oncol2005; 23(16S): 769s.
50.
WyonY.A., SpetzA.C., TheodorssonG.E., HammarM.L.Concentrations of calcitonin gene-related peptide and neuropeptide Y in plasma increase during flushes in postmenopausal women. Menopause2000; 7(1): 25–30.
51.
WyonY., WjmaK., NedstrandE., HammarM.Acomparison of acupuncture and oral estradiol treatment of vasomotor symptoms in postmenopausal women. Climacteric2004; 7(2): 153–64.
52.
FilshieJ., PennK., AshleyS., DavisC.L.Acupuncture for the relief of cancer-related breathlessness. Palliat Med1996; 10(2): 145–50.
53.
ClarkB., SitziaJ., HarlowW.Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study. QJM2005; 98(5): 343–8.
54.
FilshieJ.Safety aspects of acupuncture in palliative care. Acupunct Med2001; 19(2): 117–22.
55.
NewlandA., ProvanD., MyintS.Preventing severe infection after splenectomy. BMJ2005; 331(7514): 417–8.
56.
FilshieJ., ThompsonJ.W.Acupuncture. In: DoyleD., HanksG, ChernyN., CalmanK., editors. Oxford Textbook of Palliative Medicine.Oxford University Press; 2004. p 410–24.
57.
PowlesT., EelesR., AshleyS., EastonD., ChangJ., DowsettM.Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet1998; 352(9122): 98–101.
58.
ErnstE., CassilethB.R.The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer1998; 83(4): 777–82.
59.
LessD.B., BuschelG., RitterE., HorneberM.A.Unconventional methods in cancer patients: prevalence and patterns of use in European countries. (Abstracts of the 7th International Conference of Anticancer Research. October 25–30, 2004, Corfu, Greece). Anticancer Research2004; 24(5D): 3393–698.
60.
BerendsenH.H.The role of serotonin in hot flushes. Maturitas2000; 36(3): 155–64.
61.
HanJ.S., TereniusL.Neurochemical basis of acupuncture analgesia. Annu Rev Pharmacol Toxicol1982; 22: 193–220.
62.
WhiteA., HayhoeS., HartA., ErnstE.BMAS and AACP. British Medical Acupuncture Society and Acupuncture Association of Chartered Physiotherapists. Survey of adverse events following acupuncture (SAFA): a prospective study of 32,000 consultations. Acupunct Med2001; 19(2): 84–92.
63.
MacPhersonH., ThomasK., WaltersS., FitterM.Aprospective survey of adverse events and treatment reactions following 34,000 consultations with professional acupuncturists. Acupunct Med2001; 19(2): 93–102.
64.
FreynhagenR., StrojekK., GriesingT., WhalenE., BalkenohlM.Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain2005; 115(3): 254–63.
65.
VickersA.J., ReesR.W., ZollmanC.E., McCarneyR., SmithC.M., EllisN.Acupuncture for chronic headache in primary care: large, pragmatic, randomised trial. BMJ2004; 328(7442): 744.
